Literature DB >> 17877732

Pneumococcal meningitis in childhood: a longitudinal prospective study.

Pasquale Pagliano1, Ugo Fusco, Vittorio Attanasio, Marco Rossi, Annalisa Pantosti, Marco Conte, Francesco Saverio Faella.   

Abstract

After implementation of programmes for active immunization against Haemophilus influenzae b, Streptococcus pneumoniae and Neisseria meningitidis became the most common agents of bacterial meningitis in childhood. Over a 9-year period, children showing clinical and laboratory findings of meningitis on the basis of their positive cultures of blood or cerebro-spinal fluid (CSF) for S. pneumoniae were enrolled. Predisposing conditions, clinical and laboratory findings, and microbiological and imaging studies were considered. Meningitis-related death or neurological sequelae defined an unfavourable outcome. Sixty-four patients met the inclusion criteria. Thirty-one (48%) children had predisposing conditions to pneumococcal meningitis. Fever and neck stiffness were the main symptoms; 14 patients (22%) reported seizures before admission. Twenty-one patients required treatment in the intensive care unit (ICU). Streptococcus pneumoniae strains were penicillin susceptible in 54 cases (84%). Forty-eight children (75%) showed complete recovery. Two patients (3%) died, and 14 (22%) had sequelae. Patients with a low CSF cell count, low neutrophils, early admission to ICU or infection by penicillin-nonsusceptible strains of S. pneumoniae had an unfavourable outcome more frequently. Low blood neutrophils, low CSF cell count, early admission to ICU and infection by penicillin-nonsusceptible strains are the main factors predicting an unfavourable outcome in children with pneumococcal meningitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17877732     DOI: 10.1111/j.1574-695X.2007.00324.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  6 in total

1.  The burden of pneumococcal meningitis in Austrian children between 2001 and 2008.

Authors:  D S Klobassa; B Zoehrer; M Paulke-Korinek; U Gruber-Sedlmayr; K Pfurtscheller; V Strenger; A Sonnleitner; R Kerbl; B Ausserer; W Arocker; W Kaulfersch; B Hausberger; B Covi; F Eitelberger; A Vécsei; B Simma; R Birnbacher; H Kurz; K Zwiauer; D Weghuber; S Heuberger; F Quehenberger; H Kollaritsch; W Zenz
Journal:  Eur J Pediatr       Date:  2014-01-14       Impact factor: 3.183

2.  Factors influencing neurological outcome of children with bacterial meningitis at the emergency department.

Authors:  Fatiha Bargui; Irene D'Agostino; Patricia Mariani-Kurkdjian; Corinne Alberti; Catherine Doit; Nathalie Bellier; Laurence Morin; Giuliano Galli Gibertini; Assia Smail; Anna Zanin; Mathie Lorrot; Stéphane Dauger; Mathieu Neve; Albert Faye; Priscilla Armoogum; Antoine Bourrillon; Edouard Bingen; Jean-Christophe Mercier; Stéphane Bonacorsi; Lise E Nigrovic; Luigi Titomanlio
Journal:  Eur J Pediatr       Date:  2012-04-19       Impact factor: 3.183

3.  Early symptomatic and late seizures in Kosovar children with bacterial meningitis.

Authors:  Sadie A Namani; Ernest Kuchar; Remzie Koci; Murat Mehmeti; Kreshnike Dedushi
Journal:  Childs Nerv Syst       Date:  2011-05-20       Impact factor: 1.475

Review 4.  Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies.

Authors:  Rogier C J de Jonge; A Marceline van Furth; Merel Wassenaar; Reinoud J B J Gemke; Caroline B Terwee
Journal:  BMC Infect Dis       Date:  2010-08-05       Impact factor: 3.090

5.  Pneumococcal Meningitis and Its Sequelae - A Devastating CNS Disease.

Authors:  Monika Bekiesińska-Figatowska; Agnieszka Duczkowska; Marek Duczkowski; Hanna Brągoszewska; Jarosław Mądzik; Beata Iwanowska; Anna Romaniuk-Doroszewska; Dorota Antczak-Marach
Journal:  J Mother Child       Date:  2020-07-29

6.  NOD2 Expression in Streptococcus pneumoniae Meningitis and Its Influence on the Blood-Brain Barrier.

Authors:  Ying Wang; Xinjie Liu; Qi Liu
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-08-13       Impact factor: 2.471

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.